Car Sales Still Spe...
Health Care: Drugs
Cleveland BioLabs Inc. (CBLI: NASDAQ)
$2.07 0.80 | 62.99%
06/04/12 - 04:00 PM ET
Company Profile
| Price and Volume | |
|---|---|
| Recent Price | 1.27 |
| 52 Week High | 5.25 |
| 52 Week Low | 1.15 |
| Avg. Daily Vol. (Mil) | 0.18 |
| Beta (3 year) | 1.23 |
| Share Related Items | |
| Mkt Cap (Mil) | 45.33 |
| Shares Out (Mil) | 35.70 |
| Float (Mil) | 32.30 |
| Dividend Information | |
| Yield % | 0.00 |
| Annual Dividend | 0.00 |
| Payout Ratio | 0.00 |
| Financial Strength | |
| Quick Ratio | 2.70 |
| Current Ratio | 2.80 |
| LT Debt/ Equity | 0.03 |
| Total Debt / Equity | 0.04 |
| Valuation Ratios | |
| Price Earnings | n.a. |
| Price/Sales | 6.26 |
| Price/Book | 9.16 |
| Price/Cash Flow | -13.50 |
| Per Share Data | |
| Earnings | -0.14 |
| Sales | 0.20 |
| Book Value | 0.14 |
| Cash Flow | -0.09 |
| Business Summary | |
|---|---|
| Cleveland BioLabs, Inc. is a drug discovery and development company leveraging its proprietary discoveries around programmed cell death to develop treatments for cancer and protection of normal tissues from radiation and other stresses. | |
| General Information | |
| 73 High Street Buffalo
Buffalo, NY 14203 |
|
| www.cbiolabs.com | |
| Industry : Drugs | |
| Sector: Health Care | |
| Employees: 58 | |
| CEO: Dr. Yakov Kogan,PhD | |
| Short Interest | |
| Current Month (Mil) | 3.00 |
| Previous Month (Mil) | 2.74 |
| Short Interest Ratio (Days) | 17.50 |
| Management Effectiveness | |
| Return on Equity | n.a. |
| Return on Assets | -14.70 |
| Return on Investments | -76.00 |
| Profitability | |
| Gross Margin | n.a. |
| EBIT Margin | -81.20 |
| Profit Margin | -53.80 |
Portfolios with CBLI
- Portfolio NameUser Type
- Contributor5 Health Care Stocks With U...
- Contributor10 Surging Stocks Most at R...
- UserNEW HOME savings
- UserDan128
- UserJustchattin Portfolio 1
- UserSPQR
- UserPICKIN
- UserTom's picks
- Userboo boo
- UserSrRock33's
Latest CBLI Headlines from TheStreet
- More Biotech Twitter Mailbag: Orexigen, Affymax, YM Bio, Spectrum & More 02.29.12 | 07:02 am
- Cleveland BioLabs Stock Gaps Down On Today's Open (CBLI) 06.17.11 | 11:06 am
- Cleveland BioLabs Stock Gaps Down On Today's Open (CBLI) 05.31.11 | 09:05 am
- Biotech Stock Mailbag: Bio-Hazards 03.25.11 | 07:03 am
- 5 Health Care Stocks With Upside 03.21.11 | 11:03 am
- Surging Stocks Most at Risk of a Decline 10.28.10 | 07:10 am
- Stock Offerings: Digital Realty Trust 06.03.10 | 10:06 am
- Sunesis, Taser: Midday Volume Plays 01.06.10 | 11:01 am
- PharmAthene, ICX Technologies: Midday Volume Plays 12.30.09 | 02:12 pm
- Cleveland BioLabs Loses Out On Defense Contract 01.04.08 | 09:01 pm
Press Releases for CBLI
- Mintz Levin Represents Cleveland Biolabs, Inc. In $8.4 Million Direct Offering - Business Wire 01.04.11 | 09:01 am
Partner Headlines for CBLI
- Morning Market Movers - Benzinga 06.04.12 | 09:06 am
- Ultimate Market Recap: Medtox Makes Good, BofA Holds Out on Shareholders - Wall St. Cheat Sheet 06.04.12 | 07:06 am
- 3 Stocks Illuminating Green on a Red Trading Day - Wall St. Cheat Sheet 06.04.12 | 02:06 am
- Will the Next Apple or Google Be Found Among These Micro Caps? - Seeking Alpha 08.18.11 | 09:08 am
- Rodman & Renshaw Lower Cleveland BioLabs PT to $8 - Benzinga 06.27.11 | 04:06 pm
- Zacks #5 Rank Additions for Monday - Tale of the Tape - Zacks 06.20.11 | 09:06 am
- Future Biotech Superstars - Seeking Alpha 03.30.11 | 09:03 am
- Company News for March 16, 2011 - Corporate Summary - Zacks 03.16.11 | 10:03 am
- Morning Market Movers (SSFN, BWEN, ZNWAW, CBLI) - Benzinga 03.15.11 | 09:03 am
- Friday Options Recap - Seeking Alpha 03.11.11 | 04:03 pm
